[HTML][HTML] LncRNA LIMT (LINC01089) contributes to sorafenib chemoresistance via regulation of miR-665 and epithelial to mesenchymal transition in hepatocellular …
J Sun, X Zheng, B Wang, Y Cai, L Zheng… - Acta Biochimica et …, 2022 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the most malignant tumors worldwide and HCC
patients often develop drug resisitene. Long non-coding RNAs (LncRNAs) are closely …
patients often develop drug resisitene. Long non-coding RNAs (LncRNAs) are closely …
LncRNA LIMT (LINC01089) contributes to sorafenib chemoresistance via regulation of miR-665 and epithelial to mesenchymal transition in hepatocellular carcinoma …
S Jing, Z Xiaoxiao, W Baoming, C Ying, Z Li… - Acta Biochimica et …, 2021 - agris.fao.org
Hepatocellular carcinoma (HCC) is one of the most malignant tumors worldwide and HCC
patients often develop drug resisitene. Long non-coding RNAs (LncRNAs) are closely …
patients often develop drug resisitene. Long non-coding RNAs (LncRNAs) are closely …
LncRNA LIMT (LINC01089) contributes to sorafenib chemoresistance via regulation of miR-665 and epithelial to mesenchymal transition in hepatocellular carcinoma …
J Sun, X Zheng, B Wang, Y Cai… - Acta biochimica et …, 2022 - pubmed.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the most malignant tumors worldwide and HCC
patients often develop drug resisitene. Long non-coding RNAs (LncRNAs) are closely …
patients often develop drug resisitene. Long non-coding RNAs (LncRNAs) are closely …
LncRNA LIMT (LINC01089) contributes to sorafenib chemoresistance via regulation of miR-665 and epithelial to mesenchymal transition in hepatocellular carcinoma …
J Sun, X Zheng, B Wang, Y Cai, L Zheng… - Acta Biochimica et …, 2022 - europepmc.org
Hepatocellular carcinoma (HCC) is one of the most malignant tumors worldwide and HCC
patients often develop drug resisitene. Long non-coding RNAs (LncRNAs) are closely …
patients often develop drug resisitene. Long non-coding RNAs (LncRNAs) are closely …